Equibles does not estimate personal net worth.
Get an email with a short summary when Corcept Therapeutics Inc publishes a filing, an earnings call transcript or a press release.
Get CORT alertsCharlie Robb is recorded as CFO at Corcept Therapeutics Inc (CORT). Charlie Robb has spoken on 9 earnings calls across 1 company, most recently for Corcept Therapeutics Inc on November 3, 2026. Corcept Therapeutics Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Corcept Therapeutics Inc includes Joseph K. Belanoff (CEO and Board Member), James N. Wilson (Chairman and Board Member), Atabak Mokari (CFO) and 7 others.
“Before I answer your question directly, I just want to give folks a little bit of the history and context here. You know, we submitted our NDA originally some 20 months ago, and we received at the end of last year a complete response letter.”
“As many of you know, last Thursday, the Federal Circuit Court of Appeals ruled against us in our lawsuit to stop Teva Pharmaceuticals from marketing a generic version of Corleum in violation of our patents.”
“There is nothing new to report regarding our patent litigation with Teva Pharmaceuticals. Recall that in March 2018, we sued Teva to stop it from marketing a generic version of Corlum in violation of our patents.”
“At last, there is something to report regarding our patent litigation with Teva. Recall that in 2018, we sued Teva to keep it from marketing a generic version of Coralum in violation of our patents.”
“I'll briefly review our litigation against generic manufacturers Teva, Hikma, and Sun Pharmaceuticals. In March 2018, we sued Teva in Federal District Court to prevent it from marketing a generic version of Portland in violation of our patents.”
Biotechnology · Healthcare
CFO
